T he endothelium plays a major role in vascular homeostasis by releasing vasoactive autacoids such as nitric oxide (NO) and prostacyclin (PGI 2 ). The basal synthesis of these autacoids is greatly enhanced in the presence of receptor-dependent agonists such as acetylcholine or bradykinin as well as by receptor-independent stimuli such as hypoxia, an increase in shear stress, or cell deformation. Apart from the shear stressinduced release of NO, which is largely Ca 2+ -independent, an increase in the intracellular concentration of Ca 2+ is the common denominator for endothelial autacoid production, since both phospholipase A 2 (the rate-limiting enzyme for PGI 2 synthesis) and NO synthase are Ca 2+ -dependent enzymes (Fig. 1) .
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Discovery of an endothelium-derived hyperpolarizing factor
Over the last 10-15 years, evidence has accumulated suggesting that, in addition to NO and PGI 2 , a third vasodialatory autacoid significantly contributes to endothelium-dependent vasodilatation both in the microcirculation and in conduit arteries. Its relaxing effect, however, can only be unmasked after combined blockade of cyclooxygenase-to prevent PGI 2 formation-and NO synthase. Moreover, relaxation induced by this factor occurs secondary to smooth muscle cell hyperpolarization and is blocked by membrane depolarization [e.g., by raising extracellular K + concentration ([K + ] e ) to 40-60 mM]. Consequently, the term endothelium-derived hyperpolarizing factor (EDHF) was coined for this relaxing principle (1, 3, 5, 10, 13, 14) .
Recently, however, a major debate has evolved concerning the identity and existence of this relaxing principle, so that some researchers now tend to refer to EDHF as the "eternally deceptive relaxing factor." Several experimental problems seem to have spurred this debate, one of which is that endothelium-dependent hyperpolarization has frequently been studied without combined cyclooxygenase and NO synthase blockade. The observed changes in membrane potential, therefore, could have resulted not only from the action of EDHF but also from that of NO or PGI 2 , both of which also fulfill the criteria of an endothelium-derived hyperpolarizing factor (3, 5, 10) .
Thus NO is capable of activating Ca
2+
-dependent K + channels (K Ca channels) directly, and both K Ca channels and ATPdependent K + channels (K ATP channels) indirectly, by increasing the intracellular concentration of cGMP. PGI 2 , on the other hand, has been shown to activate smooth muscle cell K ATP channels through the secondary rise in cAMP after binding to the corresponding cell surface receptor. Moreover, both autacoids are capable of activating delayed-rectifier K + channels (K dr channels) in vascular smooth muscle cells (Fig. 1 ) by elevating the intracellular concentration of cAMP (8) . The latter effect and that of NO on K ATP channel activity is presumably brought about by preventing the breakdown of cAMP through the cGMP-inhibitable phosphodiesterase III.
Other equally important methodological problems relate to the difficulty of assaying the release of a diffusible factor from the endothelium and the use of some nonspecific pharmacological tools to elucidate both the identity and mechanism of action of EDHF (see below).
Mechanism of action
In most vascular beds studied thus far, the NO/PGI 2 -independent portion of the relaxant response to a receptor-dependent agonist is inhibited by K Ca channel inhibitors such as apamin, charybdotoxin, and tetrabutylammonium but not by the K ATP channel blocker glibenclamide (1, 3, 5, 8, 10, 13, 14) . Results with the K dr inhibitor 4-aminopyridine tend to vary, but the majority of findings suggest that the agonist-induced EDHF-mediated relaxation is not mediated by activation of K dr channels (8) . Together, these data support the concept that the hyperpolarization and hence the relaxation elicited by EDHF is mediated by the opening of K Ca channels in vascular smooth muscle cells, albeit with varying conductance depending on the vascular bed studied (Fig. 2) .
Characterization of EDHF as a diffusible factor
For some time, the hyperpolarizing factor appeared to be rather elusive, since no solid evidence-using conventional bioassay techniques-could be presented to suggest that EDHF is indeed diffusible. It was concluded, therefore, that either the NO/PGI 2 -independent vasodilatation is mediated by a factor too labile to allow its detection under bioassay conditions or that the agonist-induced hyperpolarization was propagated from endothelial cells to the underlying smooth muscle cells via myoendothelial gap junctions (cf. Fig. 2 ). Although this is a distinct possibility in the microcirculation (see below), no significant dye coupling between endothelial cells and smooth muscle cells is usually observed in conduit arteries (3, 5, 10) .
By using a novel bioassay system in which the luminal effluate of endothelium-intact bovine or porcine coronary artery segments superfuses cultured vascular smooth muscle cells, the membrane potential of which is monitored by the patchclamp technique, two groups have recently demonstrated independently from each other that a diffusible factor, pharmacologically distinct from NO and PGI 2 , is released from the endothelium of these arteries in response to bradykinin (6, 12) . This factor hyperpolarized the detector cells by activating K Ca channels with a single-channel conductance of ϳ250 pS (socalled maxi K + or BK Ca channels), and this effect was blocked both by the highly selective BK Ca channel inhibitor iberiotoxin and the broad-range K Ca channel inhibitor tetrabutylammonium (6, 11, 12) . Moreover, as K Ca channel open probability increased in the cell-attached configuration, it would appear that EDHF activates these channels indirectly, possibly involving membrane-associated second messenger pathways (6, 12) .
Epoxyeicosatrienoic acids
Although the exact chemical identity of EDHF has not yet been elucidated, a number of studies suggest that, at least in coronary arteries from many species (including human coronary arteries) and possibly also in the renal, carotid, and mesenteric arteries, a cytochrome P 450 -derived metabolite of arachidonic acid is released after stimulation with bradykinin or acetylcholine. These observations are consistent with early reports of an increased arachidonic acid and acetylcholineinduced relaxation in these blood vessels after induction of cytochrome P 450 monoxygenases (1, 11) .
There is actually a rather broad consensus that EDHF in these and other vascular preparations is an arachidonic acid metabolite or a closely related molecule. More problematic seems to be the acceptance of the term cytochrome P 450 -derived arachidonic acid metabolite. The primary reason for doubting this hypothesis is that common cytochrome P 450 inhibitors, such as clotrimazole or proadifen (SKF-525a), which effectively suppress EDHF-mediated relaxant responses, at higher concentrations also significantly impair the agonist-induced increase in intracellular Ca 2+ in endothelial cells. Moreover, they have been shown to interfere with the activation of K ATP channels and possibly also that of K Ca channels in vascular smooth muscle cells (3, 5, 10) . Inhibitors that are more selective for the cytochrome P 450 -dependent oxygenation of arachidonic acid, such as 17-octadecynoic acid (17-ODYA), on the other hand, frequently cause the problem of effectively reducing the EDHF-mediated relaxation in one preparation (e.g., bovine or porcine coronary artery) but not in another (e.g., rabbit carotid or rat mesenteric artery; Refs. 1, 6, 11-13). On the basis of these pharmacological intervention trials, several reports have been published in recent years claiming that EDHF cannot be a cytochrome P 450 -derived arachidonic acid metabolite in certain vascular beds. Indeed, no one at present would earnestly dispute that, in addition to the cytochrome P 450 -derived arachidonic acid metabolite, other types of EDHF exist in different vascular beds (see below). However, there is also a tendency toward overlooking the possibility that many cytochrome P 450 enzymes capable of oxygenating arachidonic acid exist in different vascular beds and species that are likely to display a markedly different inhibitor profile.
What, however, is the evidence arguing for EDHF being a cytochrome P 450 -derived arachidonic acid metabolite? Epoxyeicosatrienoic acids (5,6-, 8,9-, 11,12-and 14,15-EET; Fig. 3 ) are produced by endothelium-intact coronary arteries (1, 6, 8, (10) (11) (12) (13) and, when applied to endothelium-denuded coronary artery segments, are capable of producing both hyperpolarization and relaxation (1, 6, 10, 11, 13) . This hyperpolarization seems to be exclusively mediated by the activation of K Ca channels (8) , in contrast to the hyperpolarizing effects of NO or PGI 2 that can be mediated by the activation of K ATP , K Ca , and K dr channels (see above). Moreover, with the aid of the novel bioassay technique it was demonstrated that the bradykinin-induced release of EDHF from luminally perfused coronary arteries and cultured endothelial cells is not only sensitive to clotrimazole, 17-ODYA, and miconazole (6, 11, 12) but also significantly augmented by treatment of the segments or cells with ␤-naphthoflavone, an inductor of cytochrome P 450 gene expression (11) . In addition, the hyperpolarizing effect of the luminally released factor on the detector smooth muscle cells was precisely mimicked by an arachidonic acid epoxide (5,6Ϫ and 14,15-EET; Refs. 6 and 11). These epoxides, on the other hand, have been shown by various groups to activate K Ca channels in vascular smooth muscle cells, including those from the coronary arteries in question (1, 6, 10, 11, 13) . Finally, certain anesthetics that do not interfere with agonist-induced Ca 2+ mobilization in endothelial cells or K + channel activation in smooth muscle cells (e.g., thiopental) are also capable of selectively blocking the endothelium-dependent NO/PGI 2 -independent vasodilatation in different vascular beds (rabbit carotid artery, rat heart, human renal artery). This effect appears to be based on the cytochrome P 450 -inhibiting properties of these anesthetics as well (7, 11) . Additional evidence for the critical role of a cytochrome P 450 -dependent epoxygenase in bradykinininduced NO/PGI 2 -independent coronary dilatation may be derived from experiments in which expression of these enzymes (e.g., cytochrome P 450 2C8) is downregulated by using corresponding antisense oligodeoxynucleotides.
Anandamide
Recently, another arachidonic acid-like factor, anandamide (Fig. 3) , has been proposed to be an EDHF (2, 14) . The main reason for this hypothesis was that the EDHFmediated relaxation of the rat mesenteric artery is impaired by the CB 1 cannabinoid receptor antagonist SR-141716A and that the anandamide-induced relaxations in this vascular bed are both sensitive to SR-141716A and membrane depolarization through raising [K + ] e . Subsequent studies in this as well as in several other vascular preparations have demonstrated, however, that anandamide is a very poor hyperpolarizing factor and that its effects on K + channel activity in smooth muscle cells can be clearly distinguished from those of EDHF (2) . It thus seems unlikely that anandamide per se is an EDHF; however, it can be metabolized to arachidonic acid and thus serve as a precursor for the cytochrome P 450 -derived epoxides (10).
Endothelium-derived K +
The latest contribution in the quest for the identity of EDHF is a suggestion that, in the hepatic and mesenteric arteries of the rat, acetylcholine causes an activation of endothelial K Ca channels that are sensitive to apamin plus charybdotoxin but not iberiotoxin. The resulting K + efflux through these K Ca channels is supposed to double the concentration of K + in the myoendothelial space that, through activation of both inwardly rectifying K + channels (K ir channels) and Na + -K + -ATPase, hyperpolarizes and hence relaxes the adjacent smooth muscle cells (4) . Although this is undoubtedly an interesting hypothesis, it does not appear to be unequivocally supported by the data provided. Moreover, an increase in myoendothelial K + of this magnitude is unlikely to be effective in thick-walled arteries such as coronary arteries (see below), so that the authors' claim of the universal validity of their hypothesis appears to be somewhat premature. Indeed, it remains to be demonstrated that this is not simply another EDHF-like principle that is restricted to this species and type of blood vessel.
Activation of Na
ATPase by a diffusible endotheliumderived factor was already proposed a decade ago for canine coronary arteries (3, 5) ; however, the main problem associated with this hypothesis was and still is the lack of selectivity of the Na + -K + -ATPase inhibitor ouabain. Moreover, in the experiments with rat arteries, especially in the mesenteric artery preparation, there was a clear dissociation of the effects of ouabain plus barium (which was employed as a K ir channel inhibitor) on the response to acetylcholine: smooth muscle cell hyperpolarization was virtually abolished, whereas the agonist-induced relaxation remained largely unaffected. Furthermore, the concern prevails that by simply inserting a microelectrode into the space between the endothelium and the media-which is extremely difficult to achieve from a technical point of view-it seems impossible to distinguish between the rise in K + due to the opening of K + channels in the single layer of endothelial cells and the efflux of K + from the surrounding mass of smooth muscle cells due to K ir channel and Na 
Other candidates for EDHF
In addition to the epoxides, anandamide, and endothelial K + , several other candidates have been proposed as EDHF. Thus reactive oxygen species such as the hydroxyl radical or hydrogen peroxide have been suggested, but evidence for this hypothesis is rather weak, as superoxide dismutase and catalase have little or no effect on EDHF-mediated relaxations in different vascular beds. The same holds true for carbon monoxide, in particular because oxyhemoglobin, an effective scavenger of carbon monoxide, does not affect NO/PGI 2 -independent relaxation (3, 5, 10) .
Moreover, an electrical coupling between endothelial and smooth muscle cells must be considered, especially for the microcirculation, in which the relative contribution of EDHF to endothelium-dependent vasodilatation appears to be much more prominent than in conduit arteries (3, 10) . However, the apparently diffusible EDHF in conduit arteries may not necessarily represent a different relaxing principle from an electrical coupling between endothelium and vascular smooth muscle in the microcirculation. One compelling argument for this hypothesis is that, by way of sensing the filling state of inositol 1,4,5-trisphosphate-sensitive Ca 2+ stores, an epoxygenase appears to be activated in endothelial cells that metabolizes arachidonic acid to one or several of the epoxyeicosatrienoic acids. These, in turn, activate endothelial cell K Ca channels in an autocrine manner, thereby hyperpolarizing the endothelial cell membrane and, as a consequence, increasing the driving force for capacitative Ca 2+ entry (7) . In arterioles, this hyperpolarization could spread to the adjacent smooth muscle cells via myoendothelial gap junctions, thereby hyperpolarizing and hence relaxing these cells as well. This interesting hypothesis clearly warrants further investigation, which may, however, be hampered by the fact that gap junction-uncoupling agents such as halothane or octanol are rather difficult to employ in the microcirculation due to their various side effects. What seems more promising is the use of antisense oligodeoxynucleotides against the connexins that constitute the myoendothelial gap junctions (i.e., connexin 37, 40, and 43). Finally, acetylcholine-induced epoxyeicosatrienoic acid formation may also be a mechanism for the reported efflux of K + from the endothelium of the hepatic and mesenteric arteries of the rat (4).
Effects of hemodynamic forces on EDHF release
Of note in the studies with the perfused coronary artery segments was that an increase in transmural pressure in the donor segment augmented the EDHF-mediated hyperpolarization of the detector smooth muscle cells (11) . In subsequent experiments, it was demonstrated that cyclic stretching of segments alone induced a proportional increase in the release of EDHF, and this effect was abolished when the donor segments had been pretreated with 17-ODYA (12) . Because coronary arteries are unique in being continually deformed by the rhythmic contraction of the heart, it is conceivable, therefore, that cyclic deformation of the coronary endothelial cells, possibly by raising the intracellular concentration of Ca 2+ and hence the phospholipase A 2 -dependent liberation of arachidonic acid (cf. Fig. 1 ), elevates the formation of EDHF and in this way contributes to the regulation of coronary blood flow.
Conclusion(s)
The aforementioned findings suggest that, in addition to PGI 2 and NO, the vascular endothelium releases a diffusible factor that hyperpolarizes and hence relaxes the adjacent smooth muscle cells of the media. In several vascular beds, in particular in coronary arteries (including human coronary arteries), this hyperpolarizing factor displays the typical pharmacological characteristics of a cytochrome P 450 -derived arachidonic acid metabolite and exerts its effect by activating smooth muscle cell K Ca channels. Since these cells are tightly coupled electrically, hyperpolarization of only a few or the first layer of smooth muscle cells by this factor may be sufficient to elicit a decrease in tension in the entire vessel wall. In addition to the epoxide-like EDHF in the coronary circulation, however, it is likely that other, possibly related, hyperpolarizing factors exist in different vascular beds or species. 
Clinical perspective
Agonist-induced endothelium-dependent hyperpolarization in the coronary microcirculation may be a major determinant of arteriolar tone and hence of coronary blood flow. Inhibition of NO synthesis unmasks this dilator component, suggesting that, under physiological conditions, i.e., when the synthesis of NO is intact, endothelium-dependent hyperpolarization is suppressed (10) . However, in situations where the synthesis or action of NO is reduced, such as in atherosclerosis, hypercholesterolemia, or ischemia, EDHF release evoked by local mediators or pulsatile stretch may become a crucial compensatory or reserve mechanism for the maintenance of nutritive myocardial blood flow (3, 5) . In light of recent evidence that the enhanced formation of superoxide anions associated with these conditions not only leads to chemical inactivation of NO but also gives rise to the generation of peroxynitrite, a highly effective inhibitor of PGI 2 synthesis (Fig. 4; Ref. 15 ), this reserve mechanism may in fact be the last resort of the coronary circulation to escape a life-threatening vasospasm. To fulfill this function, however, both the synthesis and mechanism of action of EDHF must be insensitive to changes in the local concentration of superoxide anions or peroxynitrite, and indeed this seems to be the case. It is safe to conclude, therefore, that although its chemical nature has not yet been identified with certainty, EDHF is no longer a fiction but a fact and probably a clinically most important one.
